| Literature DB >> 27293983 |
Shideh Assar1, Mohsen Husseinzadeh2, Abdul Hussein Nikravesh3, Hannaneh Davoodzadeh4.
Abstract
Research Objective. This study determined the outcome of cardiopulmonary resuscitation (CPR) after in-hospital cardiac arrest and factors influencing it in two training hospitals in Ahvaz. Method. Patients hospitalized in the pediatric wards and exposed to CPR during hospital stay were included in the study (September 2013 to May 2014). The primary outcome of CPR was assumed to be the return of spontaneous circulation (ROSC) and the secondary outcome was assumed to be survival to discharge. The neurological outcome of survivors was assessed using the Pediatric Cerebral Performance Category (PCPC) method. Results. Of the 279 study participants, 138 patients (49.4%) showed ROSC, 81 patients (29%) survived for 24 hours after the CPR, and 33 patients (11.8%) survived to discharge. Of the surviving patients, 16 (48.5%) had favorable neurological outcome. The resuscitation during holidays resulted in fewer ROSC. Multivariate analysis showed that longer CPR duration, CPR by junior residents, growth deficiency, and prearrest vasoactive drug infusion were associated with decreased survival to discharge (p < 0.05). Infants and patients with respiratory disease had higher survival rates. Conclusion. The rate of successful CPR in our study was lower than rates reported by developed countries. However, factors influencing the outcome of CPR were similar. These results reflect the necessity of paying more attention to pediatric CPR training, postresuscitation conditions, and expansion of intensive care facilities.Entities:
Year: 2016 PMID: 27293983 PMCID: PMC4884828 DOI: 10.1155/2016/9648140
Source DB: PubMed Journal: Scientifica (Cairo) ISSN: 2090-908X
Location of occurrence of arrest.
| PICU | NICU | Emergency ward | Other wards |
| Total | |
|---|---|---|---|---|---|---|
| Number of patients | 94 (33.7%) | 89 (31.8%) | 60 (21.5%) | 36 (13%) |
| |
| Primary outcome | 50 (36.3%) | 33 (23.9%) | 33 (23.9%) | 22 (15.9%) | 0.67 |
|
| Survival to 24 h | 30 (37%) | 14 (17.3%) | 23 (28.4%) | 14 (17.3%) | 0.51 |
|
| Survival to discharge | 12 (36.4%) | 7 (21.2%) | 9 (27.3%) | 5 (15.1%) | 0.81 |
|
| Good neurological outcome | 3 (18.7%) | 5 (31.3%) | 5 (31.3%) | 3 (18.7%) | 0.63 |
|
Pre- and intraresuscitation conditions.
| Survivor ( | Nonsurvivor ( |
| |
|---|---|---|---|
|
| |||
| Monitoring | 19 (57.5%) | 169 (68.7%) |
|
| Endotracheal intubation | 4 (12.1%) | 153 (62.2%) |
|
| Continuous infusion of vasoactive drugs | 2 (6%) | 130 (52.8%) |
|
|
| |||
| Epinephrine > 0.02 mg/kg | 2 (6%) | 107 (43.5%) |
|
| Calcium injection | 4 (12.1%) | 105 (42.6%) |
|
| Bicarbonate injection | 8 (24.2%) | 174 (70.7%) |
|
| Normal saline infusion | 10 (30.3%) | 106 (43.4%) |
|
| Cardioversion | 2 (6%) | 27 (10.9%) |
|
Primary disease.
| Primary disease |
| Primary outcome | Survival to 24 h | Survival to discharge | Good neurological outcome |
|
|---|---|---|---|---|---|---|
| (i) Respiratory | 93 (33.3%) | 57 (41.3%) | 38 (46.9%) | 17 (51.5%) | 7 (43.7%) |
|
| (ii) Infection (nonrespiratory) | 52 (18.6%) | 30 (21.7%) | 16 (19.7%) | 6 (18.1%) | 4 (18.7%) |
|
| (iii) Cardiac | 43 (15.5%) | 22 (15.9%) | 12 (14.8%) | 5 (15.1%) | 3 (18.7%) |
|
| (iv) GI/hepatic | 31 (11.1%) | 11 (7.9%) | 6 (7.5%) | 2 (6.1%) | 1 (6.2%) |
|
| (v) Neurologic | 30 (10.7%) | 7 (5%) | 4 (5%) | 2 (6.1%) | 1 (6.2%) |
|
| (vi) Nephrologic | 18 (6.5%) | 7 (5%) | 2 (2.5%) | 0 | 0 |
|
| (vii) Metabolic/genetic | 12 (4.3%) | 4 (2.9) | 3 (3.7%) | 1 (3%) | 0 |
|
Age.
| <1 month | 1–12 months | 1–8 years | 9–18 years |
| |
|---|---|---|---|---|---|
|
|
|
|
| ||
| Number of patients | 98 (35.1%) | 89 (32%) | 60 (21.5%) | 32 (11.4%) | |
| Primary outcome | 42 (30.4%) | 57 (41.3%) | 26 (18.9%) | 13 (9.4%) |
|
| Survival to 24 h | 21 (25.9%) | 38 (46.9%) | 16 (19.7%) | 6 (7.5%) |
|
| Survival to discharge | 8 (24.3%) | 17 (51.5%) | 6 (18.1%) | 2 (6.1%) |
|
| Good neurological outcome | 5 (31.2%) | 7 (43.7%) | 4 (25.1%) | 0 |
|
Figure 1Duration of resuscitation.
Figure 2Time of cardiac arrest occurrence.
Gender and growth status.
| Survivor ( | Nonsurvivor ( |
| |
|---|---|---|---|
|
| |||
| Male | 18 (54.5%) | 138 (56%) |
|
| Female | 15 (45.5%) | 108 (44%) | |
|
| |||
| Normal | 23 (69.7%) | 200 (81.3%) |
|
| Overweight | 3 (9%) | 9 (3.65%) |
|
| Underweight | 7 (21.2%) | 37 (15%) |
|
Figure 3Education level of the resuscitation resident.
Figure 4Total patients.